Jason Sakamoto is a scientist and entrepreneur committed to the clinical translation of transformative medical innovation that addresses the challenges and unmet needs of human disease and patient journey. He presents a unique combination of experience that features over 20 years of innovative nanomedicine-based research and developing biotech startups, with a foundation in the medical device industry. Currently, Jason serves as Head of the TMC Innovation Biodesign Program.
Prior to joining the TMC Innovation Team, Jason served as the VP of Development at NanoMedical Systems (NMS: Austin, Texas) where he and his colleagues translated academic-based medical device technology from the drawing board to product launch (and early sales). He joined NMS in 2015 after leaving his Assistant Professor position where he served as a Co-Chair of the Department of Nanomedicine at the Houston Methodist Research Institute (HMRI). As a faculty member, he led research efforts developing novel nano-therapeutic drug delivery systems and nano-based regenerative medicine methods for lung regeneration and wound healing. He is a co-inventor of the Multistage nanoporous silicon nanovector delivery system technology that is currently on its way down the translational pathway.
Jason received his undergraduate degree in Materials Science Engineering from the University of California at Berkeley. After working at the Guidant Corporation (Santa Clara, CA) making cardiovascular and peripheral stents, he attended The Ohio State University where he received his Ph.D. in Biomedical Engineering.
Specialties: Biotech start-up experience, entrepreneurial consulting, nanomedicine, medical device, R&D/product development, cGMP manufacturing